Stock Performance and Market Context
On 17 September 2026, Yatharth Hospital & Trauma Care Services Ltd’s stock surged to an intraday high of Rs. 1,045.65, representing a 6.39% increase on the day and outperforming its sector by 5.09%. The stock closed with a day change of 6.98%, significantly outpacing the Sensex’s modest 0.18% gain on the same day. This price marks a new 52-week and all-time high, surpassing the previous 52-week peak of Rs. 1,024.95 by 2.58%.
The stock’s upward momentum is further supported by its position above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a robust technical foundation. The overall technical trend is mildly bullish, with the trend having shifted on 1 September 2026 at a price level of Rs. 974.60.
Comparative Performance Over Time
Yatharth Hospital’s stock has demonstrated exceptional relative strength over multiple time horizons compared to the broader market benchmark. Over the past week, the stock gained 7.51% while the Sensex declined by 0.58%. The one-month performance is particularly notable, with a 24.76% rise against the Sensex’s 4.20% fall. Over three months, the stock appreciated by 28.00%, contrasting with the Sensex’s 3.48% decline.
Longer-term performance also highlights the company’s strong market presence. The stock has delivered a 31.35% return over the past year, while the Sensex fell by 9.95%. Year-to-date gains stand at 54.27%, significantly outperforming the Sensex’s negative 12.62%. Over three years, the stock has surged by 171.54%, dwarfing the Sensex’s 9.77% gain. However, data for five- and ten-year returns for the stock are not available, while the Sensex recorded 26.18% and 160.38% gains respectively over those periods.
Valuation Metrics and Dividend Profile
At the current price of Rs. 1,051.40 (as of 09:58 AM on 17 September 2026), Yatharth Hospital’s valuation multiples reflect a premium consistent with its growth trajectory. The trailing twelve months (TTM) price-to-earnings (P/E) ratio stands at 52x, indicating investor willingness to pay a higher multiple for earnings. The price-to-book value (P/BV) ratio is 5.32x, while enterprise value multiples include EV/EBITDA at 30.55x and EV/EBIT at 45.31x. The EV/Sales ratio is 7.11x, and the PEG ratio is 1.91x, suggesting valuation aligned with earnings growth expectations.
Dividend yield remains modest at 0.05%, with the latest dividend declared at Rs. 0.493 per share and an ex-dividend date of 14 August 2026. Dividend payout data is not available, but the low yield indicates a focus on reinvestment and growth rather than income distribution.
Technical Analysis and Support Levels
The stock’s technical indicators present a mixed but generally positive picture. Weekly MACD is bullish, while monthly MACD is mildly bearish. Bollinger Bands show bullish tendencies weekly and mildly bullish monthly. Moving averages maintain a bullish stance, though some indicators such as KST and OBV show mild bearishness or no clear trend. The Dow Theory assessment is mildly bullish on a weekly basis.
Key technical support levels include the 52-week low at Rs. 538.15, which also serves as immediate support. Resistance levels previously encountered at Rs. 952.61 (20-day moving average), Rs. 857.68 (100-day moving average), and Rs. 765.85 (200-day moving average) have been decisively surpassed. The recent all-time high at Rs. 1,024.95 was breached, confirming the stock’s strong upward momentum.
Delivery Volumes and Market Activity
Trading activity has intensified, with delivery volumes showing a positive trend. The one-day delivery volume on 16 September 2026 was 1.24 lakh shares, representing 43.87% of total volume, exceeding the five-day average delivery volume of 73,420 shares (38.05%). Over the trailing one-month period, average delivery volume was 1.77 lakh shares (41.43% of total volume), slightly lower than the previous month’s 1.42 lakh shares (48.94%). The one-month delivery volume change stands at 24.85%, with a notable 68.49% increase in delivery volume on the most recent trading day compared to the five-day average.
Quality Assessment and Financial Trends
Yatharth Hospital & Trauma Care Services Ltd is classified as an average quality company based on long-term financial performance. The management risk is below average, while growth is rated average and capital structure is excellent. Key quality indicators include a strong interest coverage ratio of 20.46x, negligible debt with an average debt to EBITDA ratio of 0.35, and low leverage with net debt to equity at zero. The company has demonstrated healthy long-term sales growth with a five-year compound annual growth rate (CAGR) of 33.26% and EBIT growth of 19.96% over the same period.
Return on capital employed (ROCE) averages 17.68%, reflecting efficient use of capital, though return on equity (ROE) is weaker at 9.01%. Institutional holdings are moderate at 16.47%, and pledged shares constitute 9.59% of the total.
Recent Financial Performance
The short-term financial trend remains positive as of June 2026. Profit after tax (PAT) for the nine months period reached ₹139.93 crores, growing at 25.78%. Quarterly profit before depreciation, interest and tax (PBDIT) hit a high of ₹91.68 crores, while net sales for the quarter stood at ₹392.65 crores, reflecting a 31.0% increase compared to the previous four-quarter average. Profit before tax excluding other income (PBT less OI) also reached a quarterly peak of ₹56.86 crores. Debtors turnover ratio for the half-year was at its highest at 3.20 times, indicating efficient receivables management. No significant negative financial triggers were observed during this period.
Market Capitalisation and Rating Update
Yatharth Hospital & Trauma Care Services Ltd is classified as a small-cap company. The company’s Mojo Score stands at 58.0, reflecting a Hold rating by MarketsMOJO, upgraded from a previous Sell rating on 3 August 2026. This upgrade underscores the improved market sentiment and financial performance leading up to the current all-time high.
In summary, the stock’s ascent to a new all-time high of Rs. 1,045.65 on 17 September 2026 is supported by strong price momentum, robust financial results, and positive technical indicators. The company’s consistent sales and earnings growth, coupled with a solid balance sheet and improved market rating, have contributed to this milestone achievement in the hospital sector.
